Data Safety Monitoring Boards (DSMBs) in the Era of AI and Adaptive Clinical Trials
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are no longer static. Over the
adaptive studies
Trial Design in the Time of COVID-19: Complex and Efficient
Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. The current pandemic offers a chance to consider strategies for facilitating adoption of such innovative designs.